Explore our full content library.
bioMérieux vs Cepheid: Point of Care Molecular Testing Competition
Mar 27, 2026
Partner Interview
bioMrieux•FR•Mid CapRocheBio-Rad LaboratoriesDanaherAbbott LaboratoriesSwitching CostsOEMs w/ Installed BaseMar 27, 2026
Bio-Rad Laboratories: Competitive Differentiators
Oct 21, 2025
Partner Interview
Bio-Rad Laboratories•US•Large CapThermo Fisher ScientificLaboratory of AmericaRocheSwitching CostsMission Critical Products & ServicesOct 21, 2025
Bio-Rad: Switching Costs and Competitive Dynamics in Single-Cell & Digital PCR
Aug 19, 2025
Partner Interview
Bio-Rad Laboratories10X GenomicsThermo Fisher ScientificQiagenRocheBrukerBerkeley LightsIlluminaNateraCytivaGuardant HealthSwitching CostsMission Critical Products & ServicesAug 19, 2025
Sartorius: Legacy Precision Meets Commercial Friction
Jul 29, 2025
Partner Interview
Sartorius Stedim Biotech•FR•Large CapBio-Rad LaboratoriesDanaherAstraZenecaSwitching CostsMission Critical Products & ServicesJul 29, 2025
Company Profile
Danaher Biotechnology: Cytiva & Downstream Bioprocessing
Oct 8, 2024
IP Research
IP ResearchDanaher•US•Large CapSartoriusSartorius Stedim BiotechThermo Fisher ScientificMerckRepligenBio-Rad LaboratoriesSwitching CostsOEMs w/ Installed Base
Oct 8, 2024
IP Research Analysis
Danaher Cytiva: History, Moat, and Bundling Pall Filters
Oct 2, 2024
In Practise Research
IP ResearchDanaher•US•Large CapThermo Fisher ScientificMerckRepligenLonza GroupSartoriusSartorius Stedim BiotechBio-Rad LaboratoriesSwitching CostsOEMs w/ Installed Base
Oct 2, 2024
MaxCyte: Electroporation Technology, Cell & Gene Therapy & Competition
Sep 25, 2023
Partner Interview
MaxCyte•US•Small CapLonza GroupBio-Rad LaboratoriesSep 25, 2023
You've reached the end